股本结构
单位：万股
| 公告日期 | 2025-11-06 | 2025-11-06 | 2025-08-07 | 2025-08-07 | 2025-06-18 | 2025-05-12 |
|---|---|---|---|---|---|---|
| 证券总股本 | 5664.42 | 5286.29 | 5034.91 | 4028.44 | 2619.44 | 1188.44 |
| 普通股本 | 5664.42 | 5286.29 | 5034.91 | 4028.44 | 2619.44 | 1188.44 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-11-03 | 2025-09-30 | 2025-08-05 | 2025-06-30 | 2025-06-18 | 2025-05-01 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-06 | 5664.42 | 未披露 | 定期报告 | 2025-11-03 |
| 2025-11-06 | 5286.29 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Stock-based compensation
Shares issued in connection with capital raise and warrant exercises, net of transaction costs
|
2025-09-30 |
| 2025-08-07 | 5034.91 | 未披露 | 定期报告 | 2025-08-05 |
| 2025-08-07 | 4028.44 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Stock-based compensation
Shares issued in connection with capital raise, net of transaction costs
Shares withheld to pay income taxes on stock-based compensation
|
2025-06-30 |
| 2025-06-18 | 2619.44 | 未披露 |
更多>>
Common stock offered 14,310,000 shares by the company
|
2025-06-18 |
| 2025-05-12 | 1188.44 | 未披露 | 定期报告 | 2025-05-01 |
| 2025-05-08 | 526.92 | 未披露 |
更多>>
From January 1, 2025 to March 31, 2025
Stock-based compensation
Shares issued in connection with capital raise, net of transaction costs
Shares withheld to pay income taxes on stock-based compensation
|
2025-03-31 |
| 2025-03-20 | 526.92 | 未披露 | 定期报告 | 2025-03-12 |
| 2025-01-29 | 473.73 | 未披露 |
更多>>
Shares of common stock being offered 1,030,972 shares of common stock by the company
|
2025-01-29 |
| 2025-01-27 | 370.63 | 未披露 | 定期报告 | 2025-01-24 |
| 2025-03-20 | 370.26 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Shares issued in connection with capital raises, net of transaction costs
Shares issued in connection with license agreement
Shares withheld to pay income taxes on stock-based compensation
Stock-based compensation
|
2024-12-31 |
| 2024-12-20 | 369.81 | 未披露 | 定期报告 | 2024-12-19 |
| 2024-10-30 | 326.69 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Stock-based compensation
Shares withheld to pay income taxes on stock-based compensation
Shares issued in connection with capital raise, net of transaction costs
|
2024-09-30 |
| 2024-08-13 | 325.69 | 未披露 | 定期报告 | 2024-08-01 |
| 2024-08-13 | 286.89 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Stock-based compensation
Shares withheld to pay income taxes on stock-based compensation
|
2024-06-30 |
| 2024-05-28 | 285.80 | 未披露 | 定期报告 | 2024-05-17 |
| 2024-05-10 | 285.80 | 未披露 | 定期报告 | 2024-05-10 |
| 2024-04-29 | 285.79 | 未披露 | 定期报告 | 2024-04-29 |
| 2024-04-29 | 285.61 | 未披露 | 定期报告 | 2024-04-22 |
| 2024-03-29 | 285.60 | 未披露 | 定期报告 | 2024-03-21 |
| 2024-01-29 | 167.60 | 未披露 |
更多>>
Common stock offered 476,000 shares by the company
|
2024-01-30 |
| 2024-03-29 | 128.60 | 未披露 |
更多>>
Processa Pharmaceuticals, Inc. announces that in conjunction with stockholder approval of the reverse stock split on November 14, 2023, the Company’s Board of Directors, on January 8, 2024, determined to fix a split ratio of 1-for-20.
|
2024-01-22 |
| 2023-11-13 | 2463.15 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Stock-based compensation, net of forfeitures
|
2023-09-30 |
| 2023-10-05 | 2460.65 | 未披露 | 定期报告 | 2023-09-01 |
| 2023-05-15 | 2453.15 | 未披露 |
更多>>
From January 1, 2023 to March 31, 2023
Shares issued in connection with capital raises, net of transaction costs
Stock-based compensation
|
2023-03-31 |
| 2023-03-30 | 2455.76 | 未披露 | 定期报告 | 2023-03-27 |
| 2023-02-13 | 2446.76 | 未披露 |
更多>>
Common stock offered 7,812,544 shares by the company
|
2023-02-14 |
| 2023-02-13 | 1665.50 | 未披露 | 定期报告 | 2023-02-06 |
| 2023-03-30 | 1603.54 | 未披露 |
更多>>
From January 1, 2022 to December 31, 2022
Stock-based compensation
Acquisition of treasury stock
Shares issued in connection with license agreement
Shares issued in connection with the Purchase Agreement with Lincoln Park
Shares withheld to pay income taxes on stock-based compensation
|
2022-12-31 |
| 2022-11-08 | 1599.09 | 未披露 | 定期报告 | 2022-11-01 |
| 2022-11-08 | 1589.51 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Shares withheld to pay income taxes on stock-based compensation
Stock-based compensation and forfeitures
|
2022-09-30 |
| 2022-08-11 | 1585.62 | 未披露 | 定期报告 | 2022-08-04 |
| 2022-08-11 | 1581.93 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Stock-based compensation
Net loss
|
2022-06-30 |
| 2022-05-12 | 1583.75 | 未披露 |
更多>>
From January 1, 2022 to March 31, 2022
Stock-based compensation
Shares issued in connection with the Purchase Agreement with Lincoln Park
Acquisition of treasury stock
|
2022-03-31 |
| 2022-03-24 | 1584.36 | 未披露 | 定期报告 | 2022-03-23 |
| 2022-03-30 | 1571.02 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Stock-based compensation
Shares issued in private placement, net of transaction costs
Shares issued in connection with license agreements
Shares withheld to pay income taxes on stock-based compensation
Shares issued in ATM purchases, net of transaction costs
|
2021-12-31 |
| 2021-11-12 | 1571.60 | 未披露 | 定期报告 | 2021-11-02 |
| 2021-11-12 | 1559.91 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Stock-based compensation
Shares withheld to pay income taxes on stock-based compensation
|
2021-09-30 |
| 2021-08-12 | 1560.46 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Stock-based compensation
Shares issued in connection with license agreement
|
2021-06-30 |
| 2021-06-30 | 1556.63 | 未披露 | 定期报告 | 2021-06-25 |
| 2021-05-13 | 1552.16 | 未披露 |
更多>>
From January 1, 2021 To March 22, 2021
Stock-based compensation
Shares issued in private placement, net of transaction costs
|
2021-03-22 |
| 2021-03-25 | 1552.16 | 未披露 | 定期报告 | 2021-03-19 |
| 2021-03-25 | 1418.80 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Shares issued in connection with our 2020 offering, net of transaction costs of $2,099,363
Shares issued in connection with license agreements
Shares issued due to full-ratchet anti-dilution adjustment
Conversion of LOC Agreement into shares of common stock
Conversion of 8% Senior Convertible Notes into shares of common stock
Stock dividend distributed due to full-ratchet anti-dilution adjustment
Stock-based compensation
Shares withheld to pay income tax on stock-based compensation
|
2020-12-31 |
| 2020-11-12 | 1056.56 | 未披露 | 定期报告 | 2020-10-31 |
| 2020-10-05 | 1031.54 | 未披露 |
更多>>
1.Common Stock Offered by the company 4,800,000 shares of common stock.
2.The number of shares of common stock to be outstanding after this offering is based on 5,515,447 shares of common stock outstanding as of August 31, 2020
|
2020-10-02 |
| 2020-11-12 | 576.56 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Shares issued in connection with Yuhan license agreement
|
2020-09-30 |
From June 30, 2025 to September 30, 2025
Stock-based compensation
Shares issued in connection with capital raise and warrant exercises, net of transaction costs
From March 31, 2025 to June 30, 2025
Stock-based compensation
Shares issued in connection with capital raise, net of transaction costs
Shares withheld to pay income taxes on stock-based compensation
Common stock offered 14,310,000 shares by the company
From January 1, 2025 to March 31, 2025
Stock-based compensation
Shares issued in connection with capital raise, net of transaction costs
Shares withheld to pay income taxes on stock-based compensation
Shares of common stock being offered 1,030,972 shares of common stock by the company
From December 31, 2023 to December 31, 2024
Shares issued in connection with capital raises, net of transaction costs
Shares issued in connection with license agreement
Shares withheld to pay income taxes on stock-based compensation
Stock-based compensation
From June 30, 2024 to September 30, 2024
Stock-based compensation
Shares withheld to pay income taxes on stock-based compensation
Shares issued in connection with capital raise, net of transaction costs
From March 31, 2024 to June 30, 2024
Stock-based compensation
Shares withheld to pay income taxes on stock-based compensation
Common stock offered 476,000 shares by the company
Processa Pharmaceuticals, Inc. announces that in conjunction with stockholder approval of the reverse stock split on November 14, 2023, the Company’s Board of Directors, on January 8, 2024, determined to fix a split ratio of 1-for-20.
From June 30, 2023 to September 30, 2023
Stock-based compensation, net of forfeitures
From January 1, 2023 to March 31, 2023
Shares issued in connection with capital raises, net of transaction costs
Stock-based compensation
Common stock offered 7,812,544 shares by the company
From January 1, 2022 to December 31, 2022
Stock-based compensation
Acquisition of treasury stock
Shares issued in connection with license agreement
Shares issued in connection with the Purchase Agreement with Lincoln Park
Shares withheld to pay income taxes on stock-based compensation
From June 30, 2022 to September 30, 2022
Shares withheld to pay income taxes on stock-based compensation
Stock-based compensation and forfeitures
From March 31, 2022 to June 30, 2022
Stock-based compensation
Net loss
From January 1, 2022 to March 31, 2022
Stock-based compensation
Shares issued in connection with the Purchase Agreement with Lincoln Park
Acquisition of treasury stock
From December 31, 2020 to December 31, 2021
Stock-based compensation
Shares issued in private placement, net of transaction costs
Shares issued in connection with license agreements
Shares withheld to pay income taxes on stock-based compensation
Shares issued in ATM purchases, net of transaction costs
From June 30, 2021 to September 30, 2021
Stock-based compensation
Shares withheld to pay income taxes on stock-based compensation
From March 31, 2021 to June 30, 2021
Stock-based compensation
Shares issued in connection with license agreement
From January 1, 2021 To March 22, 2021
Stock-based compensation
Shares issued in private placement, net of transaction costs
From December 31, 2019 to December 31, 2020
Shares issued in connection with our 2020 offering, net of transaction costs of $2,099,363
Shares issued in connection with license agreements
Shares issued due to full-ratchet anti-dilution adjustment
Conversion of LOC Agreement into shares of common stock
Conversion of 8% Senior Convertible Notes into shares of common stock
Stock dividend distributed due to full-ratchet anti-dilution adjustment
Stock-based compensation
Shares withheld to pay income tax on stock-based compensation
1.Common Stock Offered by the company 4,800,000 shares of common stock.
2.The number of shares of common stock to be outstanding after this offering is based on 5,515,447 shares of common stock outstanding as of August 31, 2020
From June 30, 2020 to September 30, 2020
Shares issued in connection with Yuhan license agreement